ASQAX
Price
$20.66
Change
-$0.02 (-0.10%)
Updated
Jul 31 closing price
Net Assets
187.72M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

ASQAX vs VSCIX

ASQAX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
ASQAX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASQAX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. ASQAX (188M). VSCIX pays higher dividends than ASQAX: VSCIX (1.23) vs ASQAX (0.00). ASQAX was incepted earlier than VSCIX: ASQAX (26 years) vs VSCIX (29 years). ASQAX (1.10) is less costly to investors than VSCIX (0.03). ASQAX is a more actively managed with annual turnover of: 82.00 vs. VSCIX (17.00). ASQAX has a lower initial minimum investment than VSCIX: ASQAX (2500) vs VSCIX (5000000). ASQAX annual gain was more profitable for investors over the last year : 30.10 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. ASQAX (13.52).
ASQAXVSCIXASQAX / VSCIX
Total Expense Ratio1.100.033,667%
Annual Report Gross Expense Ratio1.100.033,667%
Fund Existence26 years29 years-
Gain YTD20.46614.591140%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets188M189B0%
Annual Yield % from dividends0.001.23-
Returns for 1 year30.1022.58133%
Returns for 3 years45.8843.44106%
Returns for 5 years13.5235.1338%
Returns for 10 years64.07156.0741%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C